Tango Therapeutics (TNGX) FCF Margin (QoQ) (2020 - 2025)

Tango Therapeutics (TNGX) FCF Margin (QoQ) (2020 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Tango Therapeutics 3.94 Bn 3.78 Bn -

Historic Data

Download Data
DateValue
Sep 30, 2025 109,869.00
Jun 30, 2025 -38,179.00
Mar 31, 2025 13,502.00
Dec 31, 2024 -62,634.00
Sep 30, 2024 -16,140.00
Jun 30, 2024 46,294.00
Mar 31, 2024 -10,198.00
Dec 31, 2023 -19,225.00
Sep 30, 2023 -11,807.00
Jun 30, 2023 44,395.00
Mar 31, 2023 -15,901.00
Dec 31, 2022 -7,751.00
Sep 30, 2022 15,806.00
Jun 30, 2022 -1,381.00
Mar 31, 2022 -23,278.00
Dec 31, 2021 3,193.00
Sep 30, 2021 -28,260.00
Jun 30, 2021 17,532.00
Mar 31, 2021 -19,263.00
Dec 31, 2020 -2,233.00